首页> 外国专利> INTRAPANCREATIC M2 POLARIZATION OF MACROPHAGES TO TREAT TYPE 1 DIABETES

INTRAPANCREATIC M2 POLARIZATION OF MACROPHAGES TO TREAT TYPE 1 DIABETES

机译:巨噬细胞的血管包瘤M2偏极治疗1型糖尿病

摘要

Methods are disclosed for polarizing macrophages to become M2 macrophages. Methods also are disclosed for treating type 1 diabetes in a subject. These methods include administering to the subject a vector comprising a macrophage specific promoter operably linked to a nucleic acid molecule encoding TNF-alpha-induced protein 8-like 2 (TIPE2) protein. In some embodiments, the vector is administered locally to a pancreas of the subject. In further embodiments, compositions are disclosed including a) a vector comprising a macrophage specific promoter operably linked to a nucleic acid molecule encoding TNF-alpha-induced protein 8-like 2 (TIPE2) protein; b) a buffer; and c) a contrast dye for endoscopic retrograde cholangiopancreatography.
机译:公开了用于偏振巨噬细胞以成为M2巨噬细胞的方法。还公开了用于治疗受试者的1型糖尿病的方法。这些方法包括给予受试者的载体,该载体包含与编码TNF-α-诱导的蛋白8样蛋白2(TIPE2)蛋白的核酸分子可操作地连接的巨噬细胞特异性启动子。在一些实施方案中,载体局部施用至受试者的胰腺。在进一步的实施方案中,公开了组合物,包括a)载体,其包含可操作地与编码TNF-α-诱导的蛋白8样2(TIPE2)蛋白的核酸分子可操作地连接的巨噬细胞特异性启动子的载体; b)缓冲区; c)针对内窥镜逆行胆管痴呆症的对比度染料。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号